Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Biotest AG is a prominent player in the healthcare sector, specializing in the production and development of plasma protein products and biotherapeutic drugs. The company focuses on addressing severe acute and chronic diseases by harnessing blood plasma-derived therapeutic solutions. Biotest AG's operations primarily impact the healthcare and biotechnology industries, serving key areas such as immunology, hematology, and clinical medicine. By providing crucial products like immunoglobulins, clotting factors, and albumin, Biotest AG plays a vital role in catering to the medical needs of patients with immune deficiencies, hemophilia, and other blood disorders globally. This German-based company leverages advanced technologies and innovation in plasma processing and drug development, contributing significantly to the advancement of patient care and medical treatments. Biotest AG's presence in the market underscores the growing demand for plasma-based therapies, which are essential in saving lives and improving patient outcomes across various medical conditions and regions.